Endurant Capital Management as of Sept. 30, 2020
Portfolio Holdings for Endurant Capital Management
Endurant Capital Management holds 60 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 9.1 | $31M | 91k | 337.04 | |
| Bristol Myers Squibb (BMY) | 7.0 | $24M | 390k | 60.29 | |
| Oxford Immunotec Global Ord Shs | 6.1 | $21M | 1.8M | 11.70 | |
| Encompass Health Corp (EHC) | 5.3 | $18M | 276k | 64.98 | |
| Abbvie (ABBV) | 5.2 | $17M | 199k | 87.59 | |
| Integra Lifesciences Hldgs C Com New (IART) | 3.9 | $13M | 282k | 47.22 | |
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 3.6 | $12M | 81k | 149.79 | |
| Cigna Corp (CI) | 3.4 | $11M | 68k | 169.42 | |
| Adapthealth Corp Com Cl A (AHCO) | 3.3 | $11M | 518k | 21.81 | |
| Johnson & Johnson (JNJ) | 3.3 | $11M | 75k | 148.88 | |
| Si-bone (SIBN) | 3.2 | $11M | 463k | 23.72 | |
| Zoetis Cl A (ZTS) | 2.3 | $7.8M | 47k | 165.37 | |
| Zimmer Holdings (ZBH) | 2.2 | $7.4M | 54k | 136.13 | |
| CONMED Corporation (CNMD) | 1.9 | $6.4M | 81k | 78.67 | |
| Ocular Therapeutix (OCUL) | 1.9 | $6.4M | 837k | 7.61 | |
| McKesson Corporation (MCK) | 1.8 | $6.0M | 40k | 148.94 | |
| Syneos Health Cl A | 1.8 | $6.0M | 112k | 53.16 | |
| Orthopediatrics Corp. (KIDS) | 1.7 | $5.8M | 127k | 45.92 | |
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 1.7 | $5.8M | 52k | 111.42 | |
| Trillium Therapeutics Com New | 1.6 | $5.3M | 372k | 14.21 | |
| Esperion Therapeutics (ESPR) | 1.5 | $5.1M | 136k | 37.17 | |
| Anthem (ELV) | 1.4 | $4.8M | 18k | 268.58 | |
| Sutro Biopharma (STRO) | 1.4 | $4.6M | 462k | 10.05 | |
| Insmed Com Par $.01 (INSM) | 1.4 | $4.6M | 144k | 32.14 | |
| Molecular Templates | 1.4 | $4.6M | 423k | 10.92 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 1.4 | $4.6M | 575k | 7.98 | |
| Mustang Bio | 1.3 | $4.5M | 1.4M | 3.15 | |
| Centene Corporation (CNC) | 1.3 | $4.3M | 74k | 58.33 | |
| Patterson Companies (PDCO) | 1.2 | $3.9M | 163k | 24.10 | |
| Selecta Biosciences | 1.1 | $3.7M | 1.5M | 2.48 | |
| Aclaris Therapeutics (ACRS) | 1.1 | $3.7M | 1.4M | 2.57 | |
| Vapotherm | 1.1 | $3.6M | 126k | 29.00 | |
| Haemonetics Corporation (HAE) | 1.1 | $3.6M | 42k | 87.24 | |
| PetMed Express (PETS) | 1.0 | $3.3M | 106k | 31.62 | |
| Quest Diagnostics Incorporated (DGX) | 1.0 | $3.3M | 29k | 114.49 | |
| Calliditas Therapeutics Ab Sponsered Ads | 0.8 | $2.7M | 112k | 24.00 | |
| Prothena Corp SHS (PRTA) | 0.8 | $2.6M | 263k | 9.99 | |
| Macrogenics (MGNX) | 0.7 | $2.5M | 97k | 25.19 | |
| Translate Bio | 0.7 | $2.4M | 177k | 13.61 | |
| Fate Therapeutics (FATE) | 0.7 | $2.2M | 56k | 39.98 | |
| Alcon Ord Shs (ALC) | 0.6 | $2.2M | 38k | 56.94 | |
| Aptose Biosciences Com New | 0.6 | $2.1M | 345k | 6.00 | |
| Immunic (IMUX) | 0.6 | $2.1M | 111k | 18.57 | |
| Bio Rad Labs Cl A (BIO) | 0.6 | $2.0M | 3.9k | 515.58 | |
| Five Prime Therapeutics | 0.6 | $2.0M | 421k | 4.70 | |
| Kiniksa Pharmaceuticals Com Cl A | 0.5 | $1.8M | 118k | 15.32 | |
| DaVita (DVA) | 0.5 | $1.8M | 21k | 85.66 | |
| Luminex Corporation | 0.5 | $1.8M | 68k | 26.24 | |
| Albireo Pharma | 0.5 | $1.7M | 52k | 33.38 | |
| Arcturus Therapeutics Hldg I (ARCT) | 0.4 | $1.5M | 35k | 42.89 | |
| Sage Therapeutics (SAGE) | 0.4 | $1.4M | 24k | 61.13 | |
| Cortexyme (QNCX) | 0.3 | $1.1M | 22k | 49.98 | |
| Baxter International (BAX) | 0.3 | $1.0M | 13k | 80.40 | |
| Axogen (AXGN) | 0.2 | $817k | 70k | 11.64 | |
| Senseonics Hldgs Note 5.250% 2/0 | 0.2 | $682k | 1.5M | 0.45 | |
| Inhibrx | 0.2 | $647k | 36k | 18.00 | |
| Pennant Group (PNTG) | 0.2 | $528k | 14k | 38.54 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.1 | $396k | 12k | 33.00 | |
| Aileron Therapeutics | 0.1 | $340k | 263k | 1.29 | |
| Corbus Pharmaceuticals Hldgs | 0.0 | $162k | 90k | 1.80 |
